Optimizing the management of acute ischaemic stroke: a review of the utilization of intravenous recombinant tissue plasminogen activator (tPA)

Metropolitan-rural divide for stroke outcomes: do stroke units make a difference?

(2010) D. A. Cadilhac et al.   INTERNAL MEDICINE JOURNAL

Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials

(2010) Kennedy R Lees et al.   LANCET

Prehospital stroke care: potential, pitfalls, and future

(2009) Mikael Mazighi et al.   CURRENT OPINION IN NEUROLOGY

Estimating the Long-Term Costs Of Ischemic and Hemorrhagic Stroke for Australia

(2009) Dominique A. Cadilhac et al.   STROKE

US Geographic Distribution of rt-PA Utilization by Hospital for Acute Ischemic Stroke

(2009) Dawn Kleindorfer et al.   STROKE

Efficacy and Safety of Tissue Plasminogen Activator 3 to 4.5 Hours After Acute Ischemic Stroke

(2009) Maarten G. Lansberg et al.   STROKE

Expansion of the Time Window for Treatment of Acute Ischemic Stroke With Intravenous Tissue Plasminogen Activator

(2009) Gregory J. del Zoppo et al.   STROKE

A Regional System of Stroke Care Provides Thrombolytic Outcomes Comparable With the NINDS Stroke Trial

(2008) Marian P. LaMonte et al.   ANNALS OF EMERGENCY MEDICINE

Methods and processes for the reanalysis of the NINDS tissue plasminogen activator for acute ischemic stroke treatment trial

(2008) Vicki Hertzberg et al.   Clinical Trials

Introduction of an Acute Stroke Team: An effective approach to hasten assessment and management of stroke in the emergency department

(2008) F.S. Nazir et al.   JOURNAL OF CLINICAL NEUROSCIENCE

Thrombolysis with alteplase 3–4·5 h after acute ischaemic stroke (SITS-ISTR): an observational study

(2008) Nils Wahlgren et al.   LANCET

Stroke

(2008) Geoffrey A Donnan et al.   LANCET

Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial

(2008) Stephen M Davis et al.   LANCET NEUROLOGY

Thrombolysis with Alteplase 3 to 4.5 Hours after Acute Ischemic Stroke

(2008) Werner Hacke et al.   NEW ENGLAND JOURNAL OF MEDICINE

Multivariable Analysis of Outcome Predictors and Adjustment of Main Outcome Results to Baseline Data Profile in Randomized Controlled Trials

(2008) Nils Wahlgren et al.   STROKE

Heart Disease and Stroke Statistics—2008 Update

(2007) et al.   CIRCULATION